(Q79405039)
Statements
Heterogeneous CD52 expression among hematologic neoplasms: implications for the use of alemtuzumab (CAMPATH-1H) (English)
Geraldine S Pinkus
Scott J Rodig
Jeremy S Abramson
Steven P Treon
Henry Y Dong
Jeffery L Kutok
1 December 2006